Sandhu P S, Kaul Upendra, Gupta R K, Ghose Tapan
Fortis Escorts Heart Institute and Research Center, Okhla Road, New Delhi, India.
Indian Heart J. 2013 Mar-Apr;65(2):147-51. doi: 10.1016/j.ihj.2013.02.006. Epub 2013 Feb 24.
Fractional Flow Reserve (FFR), a measure of coronary stenosis severity is based on the achievement of maximal hyperemia of coronary microcirculation. The most widely used pharmacological agent is adenosine which is administered either by intra coronary or intra venous routes. IV route is time consuming, has more side effects and expensive. This study is undertaken to compare the two routes of administration.
FFR was assessed in 50 patients with 56 intermediate focal lesions using both IV and intracoronary (IC) adenosine. FFR was calculated as the ratio of the distal coronary pressure to the aortic pressure at maximal hyperemia.
A total of 25 left anterior descending, 8 right, 21 circumflex, and 2 left main coronary arteries were evaluated. The mean percent stenosis was 63.91 ± 13.13 SD and, the mean FFR was 0.831 ± 0.0738 SD for IV and 0.832 ± 0.0707 SD for IC adenosine. There was a strong and linear correlation between 2 sets of observations with IV dose and IC adenosine dose (R = 0.964, y = 0.065 + 0.923x; p < 0.001) (y = IV dose, x = IC dose). The agreement between the two sets of measurements was also high, with a mean difference of: 0.001 ± 0.0197. The changes in heart rate and blood pressure were significantly higher in IV adenosine group. Different incremental doses were well tolerated, with fewer systemic adverse events with IC adenosine. Transient AV blocks were observed with both IV and IC adenosine.
This study suggests that IC adenosine is equivalent to IV infusion for the determination of FFR. The administration of IC adenosine is easy to use, cost effective, safe and associated with fewer systemic events.
血流储备分数(FFR)是一种评估冠状动脉狭窄严重程度的指标,其基于冠状动脉微循环最大充血状态的实现情况。最常用的药物是腺苷,可通过冠状动脉内或静脉途径给药。静脉途径耗时、副作用更多且费用昂贵。本研究旨在比较这两种给药途径。
对50例患有56处中度局灶性病变的患者,使用静脉和冠状动脉内(IC)腺苷评估FFR。FFR计算为最大充血时冠状动脉远端压力与主动脉压力之比。
共评估了25支左前降支、8支右冠状动脉、21支回旋支和2支左主干冠状动脉。平均狭窄百分比为63.91±13.13标准差,静脉注射腺苷时平均FFR为0.831±0.0738标准差,冠状动脉内注射腺苷时平均FFR为0.832±0.0707标准差。静脉注射剂量与冠状动脉内注射腺苷剂量的两组观察结果之间存在强线性相关性(R = 0.964,y = 0.065 + 0.923x;p < 0.001)(y =静脉注射剂量,x =冠状动脉内注射剂量)。两组测量结果之间的一致性也很高,平均差异为:0.001±0.0197。静脉注射腺苷组的心率和血压变化明显更高。不同递增剂量耐受性良好,冠状动脉内注射腺苷时全身不良事件较少。静脉和冠状动脉内注射腺苷均观察到短暂性房室传导阻滞。
本研究表明,冠状动脉内注射腺苷在测定FFR方面等同于静脉输注。冠状动脉内注射腺苷使用方便、成本效益高、安全且全身事件较少。